NWAM LLC’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.4M | Sell |
14,539
-136
| -0.9% | -$138K | 0.77% | 25 |
|
|
2025
Q4 | $15.6M | Sell |
14,675
-618
| -4% | -$591K | 0.87% | 20 |
|
|
2025
Q3 | $12.3M | Buy |
15,293
+1,208
| +9% | +$899K | 0.67% | 28 |
|
|
2025
Q2 | $10.5M | Buy |
14,085
+12,378
| +725% | +$9.62M | 0.61% | 31 |
|
|
2025
Q1 | $1.41M | Sell |
1,707
-11,997
| -88% | -$9.98M | 0.12% | 164 |
|
|
2024
Q4 | $10.6M | Buy |
13,704
+510
| +4% | +$422K | 0.65% | 32 |
|
|
2024
Q3 | $11.7M | Buy |
+13,194
| New | +$11.9M | 0.71% | 26 |
|
|
2024
Q2 | – | Sell |
-13,275
| Closed | -$10.3M | – | 384 |
|
|
2024
Q1 | $10.3M | Buy |
13,275
+134
| +1% | +$95.4K | 0.83% | 19 |
|
|
2023
Q4 | $7.66M | Buy |
13,141
+1,562
| +13% | +$912K | 0.62% | 29 |
|
|
2023
Q3 | $6.22M | Sell |
11,579
-1,986
| -15% | -$1.02M | 0.63% | 28 |
|
|
2023
Q2 | $6.36M | Buy |
13,565
+2,227
| +20% | +$934K | 0.52% | 36 |
|
|
2023
Q1 | $3.89M | Sell |
11,338
-162
| -1% | -$54.6K | 0.39% | 67 |
|
|
2022
Q4 | $4.21M | Buy |
11,500
+7,405
| +181% | +$2.63M | 0.37% | 69 |
|
|
2022
Q3 | $1.32M | Buy |
4,095
+236
| +6% | +$74.8K | 0.13% | 166 |
|
|
2022
Q2 | $1.26M | Hold |
3,859
| – | – | 0.12% | 173 |
|
|
2022
Q1 | $1.1M | Buy |
3,859
+405
| +12% | +$104K | 0.08% | 216 |
|
|
2021
Q4 | $954K | Buy |
3,454
+23
| +0.7% | +$5.83K | 0.08% | 230 |
|
|
2021
Q3 | $793K | Sell |
3,431
-153
| -4% | -$37.8K | 0.07% | 244 |
|
|
2021
Q2 | $823K | Buy |
3,584
+250
| +7% | +$50.2K | 0.08% | 235 |
|
|
2021
Q1 | $623K | Sell |
3,334
-284
| -8% | -$55.6K | 0.06% | 269 |
|
|
2020
Q4 | $611K | Buy |
+3,618
| New | +$540K | 0.07% | 238 |
|
|
2020
Q3 | – | Sell |
-3,806
| Closed | -$625K | – | 347 |
|
|
2020
Q2 | $625K | Buy |
3,806
+141
| +4% | +$21.6K | 0.09% | 211 |
|
|
2020
Q1 | $508 | Hold |
3,665
| – | – | 0.01% | 225 |
|
|
2019
Q4 | $482K | Buy |
3,665
+284
| +8% | +$32.9K | 0.08% | 224 |
|
|
2019
Q3 | $378K | Buy |
3,381
+50
| +2% | +$5.57K | 0.07% | 245 |
|
|
2019
Q2 | $369K | Hold |
3,331
| – | – | 0.07% | 244 |
|
|
2019
Q1 | $432K | Hold |
3,331
| – | – | 0.09% | 211 |
|
|
2018
Q4 | $385K | Buy |
+3,331
| New | +$372K | 0.1% | 197 |
|
|
2015
Q3 | – | Sell |
-3,000
| Closed | -$210K | – | 204 |
|
|
2015
Q2 | $210K | Buy |
+3,000
| New | +$229K | 0.09% | 208 |
|
|
2014
Q4 | – | Sell |
-6,216
| Closed | -$403K | – | 266 |
|
|
2014
Q3 | $403K | Sell |
6,216
-100
| -2% | -$6.33K | 0.14% | 155 |
|
|
2014
Q2 | $393K | Sell |
6,316
-325
| -5% | -$19.4K | 0.12% | 172 |
|
|
2014
Q1 | $391K | Buy |
+6,641
| New | +$371K | 0.13% | 153 |
|
|
2013
Q4 | – | Sell |
-5,776
| Closed | -$291K | – | 198 |
|
|
2013
Q3 | $291K | Sell |
5,776
-142
| -2% | -$7.43K | 0.14% | 130 |
|
|
2013
Q2 | $291K | Buy |
+5,918
| New | +$322K | 0.15% | 128 |
|
Other funds holding LLY
VCM
VPM
NWAM LLC's LLY Position: Q1 2026 in Review
NWAM LLC reduced its Eli Lilly (LLY) stake by 0.93% in Q1 2026, selling an estimated $138K and leaving 14,539 shares worth $13.4M. The position accounts for 0.77% of the portfolio, ranked #25.
NWAM LLC first reported a position in LLY in Q2 2013 and has held it in 34 quarters since. The position peaked at $15.6M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- NWAM LLC held 14,539 shares of Eli Lilly worth $13.4M as of Q1 2026.
- NWAM LLC sold 136 Eli Lilly shares in Q1 2026, an estimated $138K.
- Eli Lilly made up 0.77% of NWAM LLC's portfolio in Q1 2026, its #25 holding.
- NWAM LLC first reported a position in Eli Lilly in Q2 2013 and has held it in 34 quarters since.
- NWAM LLC's Eli Lilly position peaked at $15.6M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.